Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors
- 1 April 1988
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 84 (4) , 16-23
- https://doi.org/10.1016/0002-9343(88)90465-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalaprilAmerican Heart Journal, 1985
- ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTUREThe Lancet, 1985
- Captopril in HypertensionJournal of Cardiovascular Pharmacology, 1985
- Once-Daily Administration of Captopril and Hypotensive EffectJournal of Cardiovascular Pharmacology, 1985
- Low-Dose Captopril for the Treatment of Mild to Moderate HypertensionArchives of internal medicine (1960), 1984
- Captopril-Associated NeutropeniaArchives of internal medicine (1960), 1983
- SUCCESSFUL LOW DOSE CAPTOPRIL RECHALLENGE FOLLOWING DRUG-INDUCED LEUCOPENIAThe Lancet, 1981
- CAPTOPRIL AND AGRANULOCYTOSISThe Lancet, 1980
- Clozapine-induced agranulocytosis: A situation report up to August 1976European Journal of Clinical Pharmacology, 1977